Bhowmick Neil bought KAPA
October 8, 2025 · Form 4 insider transaction
Bhowmick Neil bought 171,756 shares of Kairos Pharma, Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 83 days after the transaction.
Direction
Acquired (buy-side)
Shares
171,756
Price
$0.00
Total value
N/A
InsiderBhowmick Neil
Role—
CompanyKairos Pharma, Ltd. (KAPA)
SecurityCOMMON STOCK
Transaction codeA: Grant or award
Transaction dateOctober 8, 2025
Filing dateDecember 30, 2025
Shares owned after1,311,739
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents 171,756 restricted stock units ("RSUs") issued to the Reporting Person under the Kairos Pharma, Ltd. 2023 Equity Incentive Plan. The 171,756 RSUs are scheduled to vest on the on the first anniversary of the grant date which is October 8, 2026.; Consists of (1) 1,135,317 shares of common stock and (2) 176,422 RSUs which remain subject to vesting.